Skip to Main Content

Paper Details

Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy.
Clin Lung Cancer
3
2022
Author NameAffiliation
Giuseppe GiacconeWeill Cornell Medical Center
Giuseppe GiacconeWeill Cornell Medical Center
  • 1 - 2

Datasets

Release 1.2